OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma
Yichen Tian, Yongrong Lei, Yuna Fu, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 6, pp. 454-462
Closed Access | Times Cited: 11
Yichen Tian, Yongrong Lei, Yuna Fu, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 6, pp. 454-462
Closed Access | Times Cited: 11
Showing 11 citing articles:
Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma
Xinxiu Li, Hongmeng Su, Wenqing Tang, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 2, pp. 185-195
Closed Access | Times Cited: 7
Xinxiu Li, Hongmeng Su, Wenqing Tang, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 2, pp. 185-195
Closed Access | Times Cited: 7
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
Hongbo Wang, Fang Chu, Xiaofeng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Hongbo Wang, Fang Chu, Xiaofeng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma
Michele Manganelli, Ilaria Grossi, Jessica Corsi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6183-6183
Open Access | Times Cited: 21
Michele Manganelli, Ilaria Grossi, Jessica Corsi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6183-6183
Open Access | Times Cited: 21
FAT10 mediates the sorafenib-resistance of hepatocellular carcinoma cells by stabilizing E3 ligase NEDD4 to enhance PTEN/AKT pathway-induced autophagy
Wenming Zhang
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1523-1544
Open Access | Times Cited: 4
Wenming Zhang
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1523-1544
Open Access | Times Cited: 4
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
Frida Ek, Kristin Blom, Tove Selvin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Frida Ek, Kristin Blom, Tove Selvin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
Hongye Wang, Zhaorong Wu, Dan Cui, et al.
Liver Research (2023) Vol. 7, Iss. 2, pp. 108-115
Open Access | Times Cited: 8
Hongye Wang, Zhaorong Wu, Dan Cui, et al.
Liver Research (2023) Vol. 7, Iss. 2, pp. 108-115
Open Access | Times Cited: 8
Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition
Tarfah Al‐Warhi, Matokah M. Abualnaja, Ola A. Abu Ali, et al.
Symmetry (2022) Vol. 14, Iss. 9, pp. 1814-1814
Open Access | Times Cited: 11
Tarfah Al‐Warhi, Matokah M. Abualnaja, Ola A. Abu Ali, et al.
Symmetry (2022) Vol. 14, Iss. 9, pp. 1814-1814
Open Access | Times Cited: 11
Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors
Kun Huang, Haikuan Liu, Yanqin Wu, et al.
La radiologia medica (2024) Vol. 129, Iss. 11, pp. 1597-1610
Closed Access
Kun Huang, Haikuan Liu, Yanqin Wu, et al.
La radiologia medica (2024) Vol. 129, Iss. 11, pp. 1597-1610
Closed Access
Ribosomal proteins in hepatocellular carcinoma: mysterious but promising
Qian Su, Huizhen Sun, Ling Mei, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access
Qian Su, Huizhen Sun, Ling Mei, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
Victoria Foy, Mairéad G. McNamara, Juan W. Valle, et al.
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8665-8685
Open Access | Times Cited: 1
Victoria Foy, Mairéad G. McNamara, Juan W. Valle, et al.
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8665-8685
Open Access | Times Cited: 1
CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis
Lingxi Chen, Hanxi Xiao, Yaran Wu, et al.
Genomics (2023) Vol. 116, Iss. 1, pp. 110764-110764
Open Access | Times Cited: 1
Lingxi Chen, Hanxi Xiao, Yaran Wu, et al.
Genomics (2023) Vol. 116, Iss. 1, pp. 110764-110764
Open Access | Times Cited: 1
